Lupin gains EIR from US FDA for its Somerset manufacturing facility

Read more

Takeda’s phase 2b study of Mezagitamab shows potential to transform treatment of primary immune Thrombocytopenia

Read more

20 years of X20

Read more

Sun Pharma’s Utreglutide shows weight loss, gluco-metabolic and lipid-lowering efficacy

Read more

EMA approves Biocon’s new mAbs facility in India

Read more

M&A trends to watch out in pharma

Read more

Margo: Edge interoperability initiative to unlock Industrial IoT

Read more

ACG Packaging Materials receives Export Award from PLEXCONCIL

Read more

Adam Fabriwerk inaugurates its New Testing Facility in Ambad, Nashik

Read more

Melodia Therapeutics and Alivexis sign exclusive licence agreement for Cathepsin C Inhibitor program MOD-A

Read more